Rationale for anti-IL-17A treatment in bullous pemphigoid

被引：0
|
作者：
Chakievska, L. [1 ]
Holtsche, M. M. [2 ]
Hammers, C. M. [2 ]
Goletz, S. [1 ]
Zillikens, D. [2 ]
Schultze, F. S. [1 ]
Hoelscher, C. [3 ]
Schmidt, E. [1 ,2 ]
机构：
[1] Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany
[2] Univ Lubeck, Dept Dermatol, Lubeck, Germany
[3] Res Ctr Borstel, Prior Area Infect, Div Infect Immunol, Borstel, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2018年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P075 (OP01
引用
收藏
页码：E31 / E32
页数：2
相关论文
共 50 条
  • [21] Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization
    Segueni, Noria
    Tritto, Elaine
    Bourigault, Marie-Laure
    Rose, Stephanie
    Erard, Francois
    Le Bert, Marc
    Jacobs, Muazzam
    Di Padova, Franco
    Stiehl, Daniel P.
    Moulin, Pierre
    Brees, Dominique
    Chibout, Salah-Dine
    Ryffel, Bernhard
    Kammuller, Michael
    Quesniaux, Valerie F.
    SCIENTIFIC REPORTS, 2016, 6
  • [22] Experimental analysis of acute murine oral candidiasis after in vivo Anti-IL-17A/IL-17F treatment and in knockout mice
    Whibley, Natasha
    Mamo, Anna J.
    Traggiai, Elisabetta
    Kolbinger, Frank
    Vogel, Beate
    Kammueller, Michael
    Siebenlist, Ulrich
    Gaffen, Sarah L.
    CYTOKINE, 2013, 63 (03) : 309 - 309
  • [23] New onset inflammatory bowel disease after initiation of anti-IL-17a treatment: a case series
    Geldof, J.
    Truyens, M.
    Strubbe, B.
    Claeys, S.
    Dewitte, G.
    Glorieus, E.
    Hoorens, A.
    Lobaton, T.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2024, 87 (03) : 413 - 417
  • [24] A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer
    Reppert, S.
    Boross, I.
    Koslowski, M.
    Tuereci, O.
    Koch, S.
    Lehr, H. A.
    Finotto, S.
    NATURE COMMUNICATIONS, 2011, 2
  • [25] Indigodole E from Strobilanthes cusia exhibits anti-IL-17A effect
    Lee, Chia-Lin
    Wang, Chien-Ming
    Yen, Hung-Rong
    Song, Ying-Chyi
    Chen, Chao-Jung
    NATURAL PRODUCT RESEARCH, 2022, 36 (23) : 5935 - 5939
  • [26] IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies
    Blauvelt, Andrew
    Lebwohl, Mark G.
    Bissonnette, Robert
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (08) : 1946 - 1953
  • [27] Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis
    Uyttenhove, Catherine
    Sommereyns, Caroline
    Theate, Ivan
    Michiels, Thomas
    Van Snicka, Jacques
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 330 - 336
  • [28] TH17/IL23 cytokine gene polymorphisms in bullous pemphigoid
    Tabatabaei-Panah, Pardis-Sadat
    Moravvej, Hamideh
    Aghaei, Sahel
    Akbari, Maryam
    Rajabi, Sakineh
    Kia, Atena
    Ebrahimi, Elaheh
    Sadaf, Zahra
    Atoon, Alireza
    Behravesh, Nasim
    Ludwig, Ralf J.
    Akbarzadeh, Reza
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (12):
  • [29] The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?
    Rodriguez Moncada, Rafael
    Vazquez Moron, Juan Maria
    Pallares Manrique, Hector
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (09) : 720 - +
  • [30] IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
    Mercurio, Laura
    Morelli, Martina
    Scarponi, Claudia
    Eisenmesser, Elan Z.
    Doti, Nunzianna
    Pagnanelli, Gianluca
    Gubinelli, Emanuela
    Mazzanti, Cinzia
    Cavani, Andrea
    Ruvo, Menotti
    Dinarello, Charles A.
    Albanesi, Cristina
    Madonna, Stefania
    CELL DEATH & DISEASE, 2018, 9
12345